Cargando…
A dramatic, objective antiandrogen withdrawal response: case report and review of the literature
Antiandrogen withdrawal response is an increasingly recognized entity in patients with metastatic prostate cancer. To our knowledge, there have been no reports describing a durable radiologic improvement along with prostate-specific antigen (PSA) with discontinuation of the antiandrogen agent bicalu...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615041/ https://www.ncbi.nlm.nih.gov/pubmed/18986533 http://dx.doi.org/10.1186/1756-8722-1-21 |